Literature DB >> 22172452

Rift Valley and West Nile virus antibodies in camels, North Africa.

Mehdi El-Harrak, Raquel Martín-Folgar, Francisco Llorente, Paloma Fernández-Pacheco, Alejandro Brun, Jordi Figuerola, Miguel Angel Jiménez-Clavero.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22172452      PMCID: PMC3311197          DOI: 10.3201/eid1712.110587

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Different arboviral diseases have expanded their geographic range in recent times. Of them, Rift Valley fever, West Nile fever, and African horse sickness are of particular concern. They are endemic in sub-Saharan Africa but occasionally spread beyond this area. Trade and transport of animals and animal products, along with wildlife movements, are considered the driving factors in the spread of these pathogens. In wide regions of Africa, 1-humped camels (Camelus dromedarius) are valuable livestock appreciated as a meat source and as a means for transportation of goods. Camels are susceptible to infection by Rift Valley fever virus (RVFV), West Nile virus (WNV), and African horse sickness virus (AHSV), although their epidemiologic role in these diseases is uncertain (–). Movements of camels across the Sahara Desert could carry these pathogens to northern Africa. To test this hypothesis, we conducted a serologic survey in 1-humped camels intercepted at different points by the Moroccan Veterinary Services in 2009. The camels were coming from the southeastern part of the Sahara Desert going to the northwest. Serum samples were obtained in Smara-Laayoune, Dakhla, and Tata (Table). Most samples (71 of 100 total samples) were from male camels. Samples were also grouped by age of the camels (Table). RVFV antibodies were detected by using a competitive ELISA (), and samples yielding positive ELISA results were confirmed by virus-neutralization test. WNV-specific antibodies were detected by ELISA (), and positive results were confirmed by virus-neutralization test. AHSV-specific antibodies were detected by using the ELISA prescribed by the World Organisation for Animal Health.
Table

Results of testing of camels for virus antibodies, by location, age group, and sex of camels examined, North Africa, 2009*

Camel characteristicNo. samplesNo. positive for antibody
RVFVWNVAHSVRVFV and WNV
Origin
Tata20000
Smara-Laayoune581320011
Dakhla402901
Age group, y
<1181101
1–2250100
3–571301
6–1027612010
>102371200
Sex
M71101507
F2951405
Total1001529012

*RVFV, Rift Valley fever virus; WNV, West Nile virus; AHSV, African horse sickness virus.

*RVFV, Rift Valley fever virus; WNV, West Nile virus; AHSV, African horse sickness virus. Fifteen of 100 samples were positive for RVFV-specific antibodies by competitive ELISA, all of which were confirmed by virus-neutralization test, with neutralization titers ranging from 40 to 1,280 (geometric mean titer = 229). With regard to WNV antibodies, the ELISA detected 44 positive samples and 1 doubtful sample, of which 29 were confirmed as positive by virus-neutralization test (virus-neutralization test titers ranging from 10 to 640; geometric mean titer = 20). As for AHSV antibodies, none of the samples was positive by ELISA. Prevalence data were analyzed by generalized linear model with locality (Dakhla or Smara), sex, and age as fixed factors. No differences by origin or sex were found in prevalence for WNV (p>0.14) but antibodies were more prevalent in camels >3 years of age (χ2 = 14.04, 3 df, p = 0.003). No differences in prevalence of RVFV antibodies were found by sex (p = 0.29), but prevalence was higher in Smara (χ2 = 3.74, p = 0.05) and among camels >6 years of age (χ2 = 8.37, df = 3, p = 0.04) (Table). We also examined the co-occurrence of antibodies to RVFV and WNV. Of 15 RVFV-positive samples, 12 were also positive for WNV antibodies, and 12 of 29 WNV-positive samples were also positive for RVFV (χ2 = 8.37, df = 1, p < 0.05). Antibodies to 2 zoonotic arboviruses, i.e., RVFV and WNV, were present in camels moving to the northwestern part of the Sahara Desert, and antibodies to AHSV were absent in the populations examined. Despite the higher percentage of seropositivity for WNV than for RVFV, the epidemiologic consequence of RVFV-specific antibodies in this population could be higher than that for WNV antibodies. Camels can act as reservoir hosts for RVFV () but are unlikely to do so for WNV, which cycles between mosquitoes and wild birds with mammals usually being dead-end hosts. High prevalence of antibodies to RVFV in camels has been described in different sub-Saharan and Sahelian countries (–). Camels have been involved in the spread of disease in some instances (). Immunity to RVFV indicates previous infection. Our results showed that seroprevalence of RVFV was higher among older than younger camels, indicating that contact could have occurred some years ago. Nevertheless, these populations should be monitored for RVFV and other arboviroses because these are known to reemerge under certain circumstances in locations where they have occurred in the past. The results of this study support that camels moving across the Sahara have contact with RVFV and WNV, and frequently the same animals have been infected by both agents. In a particularly dry environment such as the desert, particular attention should be paid to singular wet areas such as oases. The presence of water in these areas results in an abundance of competent mosquitoes and hosts, which in turn makes these viruses likely to cycle and infect domestic animals such as camels coming to drink and rest.
  10 in total

1.  An epizootic of Rift Valley fever in Egypt in 1997.

Authors:  I H Abd el-Rahim; U Abd el-Hakim; M Hussein
Journal:  Rev Sci Tech       Date:  1999-12       Impact factor: 1.181

2.  Rift Valley fever in camels.

Authors:  G R SCOTT; W COACKLEY; R W ROACH; N R COWDY
Journal:  J Pathol Bacteriol       Date:  1963-07

3.  Rift Valley fever in Nigeria: infections in domestic animals.

Authors:  O D Olaleye; O Tomori; H Schmitz
Journal:  Rev Sci Tech       Date:  1996-09       Impact factor: 1.181

4.  Preliminary survey of domestic animals of the Sudan for precipitating antibodies to Rift Valley fever virus.

Authors:  M Eisa
Journal:  J Hyg (Lond)       Date:  1984-12

5.  Development and evaluation of a new epitope-blocking ELISA for universal detection of antibodies to West Nile virus.

Authors:  Elena Sotelo; Francisco Llorente; Belen Rebollo; Ana Camuñas; Angel Venteo; Carmina Gallardo; Alison Lubisi; María José Rodríguez; Antonio J Sanz; Jordi Figuerola; Miguel Ángel Jiménez-Clavero
Journal:  J Virol Methods       Date:  2011-03-17       Impact factor: 2.014

6.  Development and characterization of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein generated by DNA immunization.

Authors:  Raquel Martín-Folgar; Gema Lorenzo; Hani Boshra; Javier Iglesias; Francisco Mateos; Belén Borrego; Alejandro Brun
Journal:  MAbs       Date:  2010-05-02       Impact factor: 5.857

Review 7.  African horse sickness.

Authors:  Philip Scott Mellor; Christopher Hamblin
Journal:  Vet Res       Date:  2004 Jul-Aug       Impact factor: 3.683

8.  Antibodies to hemorrhagic fever viruses in domestic livestock in Niger: Rift Valley fever and Crimean-Congo hemorrhagic fever.

Authors:  J C Mariner; J Morrill; T G Ksiazek
Journal:  Am J Trop Med Hyg       Date:  1995-09       Impact factor: 2.345

9.  West Nile: worldwide current situation in animals and humans.

Authors:  Gwenaëlle Dauphin; Stéphan Zientara; Hervé Zeller; Bernadette Murgue
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2004-09       Impact factor: 2.268

10.  Factors associated with rift valley fever in south-west Saudi Arabia.

Authors:  A A Elfadil; K A Hasab-Allah; O M Dafa-Allah
Journal:  Rev Sci Tech       Date:  2006-12       Impact factor: 1.181

  10 in total
  14 in total

1.  Comprehensive phylogenetic reconstructions of Rift Valley fever virus: the 2010 northern Mauritania outbreak in the Camelus dromedarius species.

Authors:  Ahmed B El Mamy; Modou M Lo; Yaya Thiongane; Mariame Diop; Katia Isselmou; Baba Doumbia; Mohammed Ould Baba; Ahmed S El Arbi; Renaud Lancelot; Y Kane; Emmanuel Albina; Catherine Cêtre-Sossah
Journal:  Vector Borne Zoonotic Dis       Date:  2014-12       Impact factor: 2.133

2.  Over 100 Years of Rift Valley Fever: A Patchwork of Data on Pathogen Spread and Spillover.

Authors:  Gebbiena M Bron; Kathryn Strimbu; Hélène Cecilia; Anita Lerch; Sean M Moore; Quan Tran; T Alex Perkins; Quirine A Ten Bosch
Journal:  Pathogens       Date:  2021-06-05

3.  Animal viral diseases and global change: bluetongue and West Nile fever as paradigms.

Authors:  Miguel Á Jiménez-Clavero
Journal:  Front Genet       Date:  2012-06-13       Impact factor: 4.599

4.  First isolation of West Nile virus from a dromedary camel.

Authors:  Sunitha Joseph; Ulrich Wernery; Jade Ll Teng; Renate Wernery; Yi Huang; Nissy Ag Patteril; Kwok-Hung Chan; Shyna K Elizabeth; Rachel Yy Fan; Susanna Kp Lau; Jörg Kinne; Patrick Cy Woo
Journal:  Emerg Microbes Infect       Date:  2016-06-08       Impact factor: 7.163

5.  Towards the description of livestock mobility in Sahelian Africa: Some results from a survey in Mauritania.

Authors:  Andrea Apolloni; Gaëlle Nicolas; Caroline Coste; Ahmed Bezeid El Mamy; Barry Yahya; Ahmed Salem El Arbi; Mohamed Baba Gueya; Doumbia Baba; Marius Gilbert; Renaud Lancelot
Journal:  PLoS One       Date:  2018-01-24       Impact factor: 3.240

6.  Serosurvey of Coxiella burnetii (Q fever) in Dromedary Camels (Camelus dromedarius) in Laikipia County, Kenya.

Authors:  A S Browne; E M Fèvre; M Kinnaird; D M Muloi; C A Wang; P S Larsen; T O'Brien; S L Deem
Journal:  Zoonoses Public Health       Date:  2017-02-08       Impact factor: 2.702

Review 7.  Surveillance of Arthropod-Borne Viruses and Their Vectors in the Mediterranean and Black Sea Regions Within the MediLabSecure Network.

Authors:  Anna-Bella Failloux; Ali Bouattour; Chafika Faraj; Filiz Gunay; Nabil Haddad; Zoubir Harrat; Elizabeta Jancheska; Khalil Kanani; Mohamed Amin Kenawy; Majlinda Kota; Igor Pajovic; Lusine Paronyan; Dusan Petric; Mhammed Sarih; Samir Sawalha; Taher Shaibi; Kurtesh Sherifi; Tatiana Sulesco; Enkelejda Velo; Lobna Gaayeb; Kathleen Victoir; Vincent Robert
Journal:  Curr Trop Med Rep       Date:  2017-03-17

8.  First Serological Evidence of Crimean-Congo Hemorrhagic Fever Virus and Rift Valley Fever Virus in Ruminants in Tunisia.

Authors:  Khaoula Zouaghi; Ali Bouattour; Hajer Aounallah; Rebecca Surtees; Eva Krause; Janine Michel; Aymen Mamlouk; Andreas Nitsche; Youmna M'ghirbi
Journal:  Pathogens       Date:  2021-06-18

9.  Safety and immunogenecity of a live attenuated Rift Valley fever vaccine (CL13T) in camels.

Authors:  S Daouam; F Ghzal; Y Naouli; K O Tadlaoui; M M Ennaji; C Oura; M El Harrak
Journal:  BMC Vet Res       Date:  2016-07-26       Impact factor: 2.741

Review 10.  Systematic literature review of Rift Valley fever virus seroprevalence in livestock, wildlife and humans in Africa from 1968 to 2016.

Authors:  Madeleine H A Clark; George M Warimwe; Antonello Di Nardo; Nicholas A Lyons; Simon Gubbins
Journal:  PLoS Negl Trop Dis       Date:  2018-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.